LTRN
LTRN
NASDAQ · Biotechnology

Lantern Pharma Inc

$1.09
-0.13 (-10.66%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,283.5% upside
Low Target $20.93
Average Target $25.98
High Target $39.39
Current Price $1.09
Current
$1.09
Target
$25.98
$20.93 $25.98 avg $39.39
Scenario Analysis
Bear Case
$20.93
1,820.2%
Low target
Base Case
$25.98
+2,283.5%
Avg target
Bull Case
$39.39
+3,513.8%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.70
-76.8% from high
52-Week Low
$1.11
+-1.8% from low
Target vs 52W High
$25.98
+452.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%